These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 2990704)
21. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico]. Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666 [No Abstract] [Full Text] [Related]
26. HTLV-III antibodies in hemodialysis patients--a consequence of blood transfusions? Schaefer K; Asmus G; Hüfler M; von Herrath D Klin Wochenschr; 1986 Jul; 64(13):621-2. PubMed ID: 3018352 [TBL] [Abstract][Full Text] [Related]
27. Clinical spectrum of HTLV-III in humans. Groopman JE Cancer Res; 1985 Sep; 45(9 Suppl):4649s-4651s. PubMed ID: 2990701 [TBL] [Abstract][Full Text] [Related]
28. [HTLV-III infection in risk groups]. Esteban R; Buti M; Esteban JI; Hernández JM; Jardí R; Vila M; Tusell J; Guardia J Med Clin (Barc); 1986 Jan; 86(3):110-2. PubMed ID: 3007880 [No Abstract] [Full Text] [Related]
29. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients. Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791 [TBL] [Abstract][Full Text] [Related]
30. HTLV and immunosuppression. Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649 [TBL] [Abstract][Full Text] [Related]
31. AIDS and the spectrum of HTLV-III/LAV infection. Pinching AJ; Weiss RA Int Rev Exp Pathol; 1986; 28():1-44. PubMed ID: 2870992 [No Abstract] [Full Text] [Related]
32. Serological characterization of HTLV-III infection in AIDS and related disorders. Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434 [TBL] [Abstract][Full Text] [Related]
33. [Initial manifestation of acquired immunodeficiency syndrome (AIDS) in the nervous system]. Jürgens R; Thun F; Ackermann R Nervenarzt; 1985 Nov; 56(11):603-7. PubMed ID: 3001544 [No Abstract] [Full Text] [Related]
34. AIDS: clinical signposts for the Virginia physician. Cader AM Va Med; 1986 Apr; 113(4):225-7. PubMed ID: 3012898 [No Abstract] [Full Text] [Related]
35. AIDS in Alabama. The first 1,000 days. Alexander WJ Ala J Med Sci; 1986 Jul; 23(3):265-9. PubMed ID: 3019170 [No Abstract] [Full Text] [Related]
36. AIDS: the significance of anti-HTLV-III antibodies. Robinson PA; Brough J; Haddy L; Belshe RB; Khakoo R; Stevenson MM W V Med J; 1985 Sep; 81(9):194-7. PubMed ID: 2998098 [No Abstract] [Full Text] [Related]
37. The natural history of human T lymphotropic virus-III infection: the cause of AIDS. Melbye M Br Med J (Clin Res Ed); 1986 Jan; 292(6512):5-12. PubMed ID: 3002536 [No Abstract] [Full Text] [Related]
38. An overview of the HTLV Symposium and reflections about the past, present, and future. Gross L Cancer Res; 1985 Sep; 45(9 Suppl):4706s-4709s. PubMed ID: 2861897 [No Abstract] [Full Text] [Related]